s6y
Company name or ticker
Search
Dianthus Therapeutics, Inc. /DE/
DEF 14A
Definitive proxy statements
Filed
Wednesday, April 21, 2021
Period
Jun 1, 2021
Accession number
0001193125-21-123656
Documents
DEF 14A
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header